This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks With Big Insider Buying

Opko Health

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Another biotech stock whose insiders are doing some big buying in is Opko Health (OPK - Get Report), which is focused on developing a range of solutions, including molecular diagnostics tests, pharmaceuticals and vaccines. Opko operates in two segments: pharmaceutical and instrumentation segments. Insiders are paying up here to own shares of this name since the stock is up over 10% so far in 2011.

Opko Health has a market cap of $1.2 billion and an enterprise value of $1.1 billion. This company is currently not profitable yet. Its operating cash flow is -$21.1 million, and its levered free cash flow is -$22 million. Opko is cash-rich, however, with $107.86 million in cash on its books and just $14.55 million in debt. After you back out the debt, that gives the company $93.31 million in cash.

The CEO, chairman of the board and director just bought 100,000 shares, or $412,064 worth of stock, at $4.12 per share. This same CEO has been steadily buying millions worth of OPK stock since 2010. It's hard to make a bearish case against a stock where the CEO has been buying up shares as consistently as at OPK.

From a technical standpoint, this stock is trading above both its 50-day and 200-day moving averages, which is bullish. The stock has also been making higher lows and higher highs since the middle of June, which shows that the trend is positive.

If you're looking to get long OPK, I would wait until the stock breaks out above some near-term overhead resistance at around $4.40 to $4.50 a share. I would then add aggressively to any long position if you see OPK trigger a major breakout above $5.03 a share on solid volume. Look for a volume move that registers close to or over the three-month average action of 988,000 shares. Another way to play this name would be to buy it on any weakness as long as it holds above its 50-day ($3.83) and 200-day ($3.72) moving averages.

It's worth mentioning that OPK has a decent amount of short-sellers involved in the stock. The current short interest as a percentage of the float for OPK stands at 8%. If you see this stock break out, then expect a sharp short-covering rally to ensue as the bears peel off some of their bets.

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CELG $118.68 0.00%
BXC $1.04 0.00%
INFN $19.59 0.00%
OPK $14.49 0.00%
RLD $12.16 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs